NDAORALTABLET, ORALLY DISINTEGRATING, DELAYED RELEASE
Approved
Jul 2017
Lifecycle
Peak
Competitive Pressure
0/100
Clinical Trials
20
Mechanism of Action
Proton Pump Inhibitors
Pharmacologic Class:
Proton Pump Inhibitor
Clinical Trials (5)
A Study to Learn if Taking BIIB141 (Omaveloxolone) Affects How Omeprazole is Processed in the Body and About BIIB141's Safety in Healthy Adults Aged 18 to 55
Started Sep 2025
22 enrolled
Healthy Volunteer
A Study of Food Effect and Esomeprazole on LY4064809 in Healthy Adult Participants
Started May 2025
36 enrolled
Healthy
Drug-drug Interaction Study of Omeprazole and Bemnifosbuvir/Ruzasvir
Started May 2025
20 enrolled
Healthy Volunteer Study
A Study to Investigate the Relative Bioavailability of 2 Different Formulations of AZD4144, the Effect of Food and Omeprazole on the Pharmacokinetics of AZD4144 in Healthy Participants
Started Apr 2025
32 enrolled
Healthy Participants
A Study in Healthy Men to Test Whether Zongertinib Affects How 3 Other Medicines (Midazolam, Omeprazole, and Repaglinide) Are Taken up and Processed by the Body
Started Jul 2024
16 enrolled
Healthy
Loss of Exclusivity
LOE Date
Dec 8, 2036
131 months away
Patent Expiry
Dec 8, 2036